Takara Bio drives Japan’s quest for a coronavirus vaccine

Takara Bio drives Japan’s quest for a coronavirus vaccine

OSAKA — As nations scramble to develop vaccines for the coronavirus, Takara Bio is at the forefront of Japan’s efforts, tapping its four decades of gene-editing experience to help develop a DNA-based approach that has never been used in humans before. The...
Thailand begins coronavirus vaccine trials on monkeys

Thailand begins coronavirus vaccine trials on monkeys

BANGKOK (Reuters) — Thailand on Saturday began testing a vaccine against the coronavirus on monkeys after positive trials in mice, an official said. Thailand’s minister of higher education, science, and research and innovation, Suvit Maesincee, said...
Japan’s AGC joins project to develop coronavirus DNA vaccine

Japan’s AGC joins project to develop coronavirus DNA vaccine

TOKYO — Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage. The DNA vaccine project is a...
Coronavirus tests India’s vaccine makers in R&D capability

Coronavirus tests India’s vaccine makers in R&D capability

MUMBAI/NEW DELHI — At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability. The World Health...
WHO calls for fair access to vaccine through patent limits

WHO calls for fair access to vaccine through patent limits

GENEVA — As the race for a COVID-19 vaccine heats up, the World Health Organization is looking to limit the drug patents of the eventual developer to give all countries equal access — an idea that does not sit well with the U.S., whose drugmakers are...